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ABSTRACT
Background: While mortality rates for cardiovascular disease have declined, many patients still fail to
receive effective and timely care. Studies report that characteristics including census region of the
United States (Midwest, West, Northeast and South), neighborhood classification (urban, rural,
suburban), and teaching status are all associated with the quality of care provided. It has been reported
that national quality improvement campaigns have been shown improve the quality of AMI care for
these patients and increase compliance to guideline recommended treatment. Use of defect-free
composite measures is increasing as they promote full execution of all processes of care, encourage a
focus on the whole sequence of care instead of individual components, and offer a more sensitive scale
to judge improvement in situations of already high compliance. The aforementioned hospital
characteristics have not been analyzed using this defect-free composite measure as the outcome. This
study aims to evaluate the degree to which hospital performance varied on the “all-or-none” composite
measure and to identify hospital characteristics that were predictive of higher rates of defect-free care.
Methods: Using data from the National Cardiovascular Data Registry (NCDR) – Acute Coronary
Treatment and Intervention Outcomes Network (ACTION) – Get With the Guidelines (AR-G) [NCDR AR-G]
a total of 791,354 patients and 1,332 hospitals were analyzed. The “all-or-none” defect-free composite
consisting of 11 ACC/AHA recommended guidelines was the primary outcome. The association between
defect-free care and the hospital characteristics of interest was determined by multivariate logistic
regression.
Results: Hospitals located in the Midwest and Northeast regions of the US were more likely to provide
defect-free care (OR [95% CI]: 1.79 [1.73, 1.86] and 1.13 [1.07, 1.20], respectively) than hospitals in the
South; while hospitals located in rural or suburban areas were less likely (OR [95% CI]: 0.83 [0.80, 0.87]
and 0.95 [0.92, 0.98]) to provide defect-free care than hospitals in urban areas. In addition, teaching
hospitals are less likely to provide defect-free care (OR [95% CI]: 0.96 [0.93, 0.99]) than hospitals that are
non-teaching. Hospitals in all categories demonstrated positive trends in compliance throughout the
study period.
Conclusions: In order to move from already high rates of compliance to full compliance, it must be
recognized that hospital level variations in care still exist. This continued variation in care by hospital
characteristics suggests that the institutions within each category face unique challenges. Studies are
needed to identify these challenges and propose potential solutions.
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Hospital Variation in Performance for Acute Myocardial Infarction with the NCDR ACTION RegistryGWTG "All-or-None” Composite Measure

BACKGROUND
Cardiovascular disease remains the leading cause of mortality in the US. While mortality rates have
declined, many patients still fail to receive effective and timely care [1]. National quality improvement
campaigns have been implemented in an effort to improve care for individuals with the disease and to
reduce morbidity and mortality [2]. These quality improvement campaigns utilize evidence based
performance indicators, including process of care measures, to reflect the quality of care at each
institution [3]. Quality of care is assessed based upon performance on the recommendations
individually, or by performance on composite measures [4].
The defect-free composite outcome is an “all-or-none” summary measure. The measure contains
the aforementioned treatment recommendations for AMI care such as pharmacotherapy, timely
reperfusion and referral to cardiac rehabilitation programs [5]. This measure presents information
different from that of an item-by-item approach as it describes overall quality of care and adherence to
guidelines and promotes a high standard of excellence [4-5]. The use of the defect-free composite
measure is increasing because it promotes full execution of all processes of care, encourages a focus on
the whole sequence of care instead of individual components, and offers a more sensitive scale to judge
improvement in situations of already high compliance [4]. Additionally, studies have found an inverse
association between composite compliance and in hospital mortality [3,7].
Studies report that characteristics including census region of the United States (Midwest, West,
Northeast and South), neighborhood classification (urban, rural, suburban), and teaching status are all
associated with quality of care provided, with higher compliance to guideline recommended care in the
northeast, urban hospitals and teaching hospitals [8-13]. Previous studies have identified that the
campaigns have been shown to improve the quality of care for patients with coronary artery disease
(CAD) [14-15] and investigators have reported positive trends in adherence to individual process of care
measures [16]. However, the aforementioned hospital characteristics have not been analyzed using the
defect-free composite measure as the outcome.
Therefore, using data from the National Cardiovascular Data Registry (NCDR) – Acute Coronary
Treatment and Intervention Outcomes Network (ACTION) – Get With the Guidelines (AR-G) [NCDR ARG], this study examines the association between teaching status, census region of the US and
6
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neighborhood classification of hospitals and use of defect-free care in order to evaluate the degree to
which hospital performance varied on the “all-or-none” composite measure and to identify hospital
characteristics that were predictive of higher rates of defect-free care.

METHODS
NCDR ACTION Registry Get With the Guidelines (NCDR AR-G)
NCDR ACTION Registry Get With the Guidelines Program was launched in 2007 through a merger of
the American College of Cardiology’s (ACC) ACTION with the National Registry of Myocardial Infarction
and Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early
(CRUSADE) of the ACC/American Heart Association (AHA). A year later the registry again merged with
the AHA’s GWTG-Coronary Artery Disease Program [17]. The final registry represents a unified effort to
assess the characteristics and outcomes of patients with AMI and utilize evidence based treatment
methods to improve national acute myocardial infarction care and improve patient outcomes [5].
The methods of the NCDR AR-G have been described previously [5]. Briefly, all data elements are
abstracted via chart review of participating hospitals and submitted via a secure, password-protected,
web based server programmed to optimize data quality at the time of entry. The collected data
elements were selected by the AR-G Steering Committee and chosen to maximize quality improvement
efforts. They are composed of the core set of ACC/AHA Performance Measures and Class I
Recommendations of the ACC/AHA clinical practice guidelines [18]. These two sets of practice guidelines
are used as definitions of performance and quality metrics and are presented in quarterly benchmarked
reports to participating hospitals [17]. In addition to performance measures and clinical practice
guidelines, patient demographics, presenting features, prehospital therapy, in-hospital therapy, hospital
discharge therapy, timing of care delivery, laboratory tests, procedures, and patient outcomes are
collected [5]. The ACC/AHA Performance Measures, as well as examples of additional ACTION AR-G data
elements are presented in Tables 1 and 2 in the Appendix. Data elements are abstracted by trained
personnel via chart review and entered into a secure, password-protected, web-based, server system
[5].
The AR-G includes patients with a primary diagnosed of STEMI or NSTEMI as defined by (1) ischemic
symptoms at rest, lasting ≥ 10 minutes, occurring within 24 hours before admission or up to 72 hours for
STEMI; (2) ECG changes associated with STEMI (new left bundle-branch block [LBBB] or persistent ST
segment elevation ≥ 1 mm in 2 or more contiguous electrocardiographic leads); or (3) positive cardiac
7

Running head: HOSPITAL VARIATION IN DEFECT FREE CARE
markers associated with NSTEMI (CK-MB or Troponin I/T > local laboratory upper limit of normal values)
within 24 hours after initial presentation. Transfer patients meeting these criteria must arrive at the
participating hospital within 72 hours of the time of initial presentation to the outside hospital. Patients
are ineligible for the AR-G if ischemic symptoms are developed during the hospital stay, but originally
presented with symptoms unrelated to STEMI or NSTEMI. Cases are identified retrospectively through
chart review [5].
Exclusion Criteria
This analysis includes all eligible adults (age ≥ 18) cared for at hospitals in the registry between
January 1, 2010 and December 31, 2014. Since previous research has shown that participation in GWTG
is independently associated with improvements in guideline adherence, the study cohort was further
limited to hospitals that continuously participated in the registry during the study period [19].
Continuous participation was defined as a minimum of 50 cases per year during the study period to
ensure adequate sample size to estimate hospital performance. The institutional review board for the
AR-G Analytic Center located at the Duke Clinical Research Institute approved use of this data.
“All-or-None” Defect-Free Composite Measure
An evidence based composite quality measure was used to describe quality of care by hospital
characteristics. This composite score is composed of the following for the STEMI population:
(1) Aspirin at Arrival, (2) Aspirin prescribed at Discharge, (3) Beta-Blocker Prescribed at Discharge, (4)
Statin Prescribed at Discharge, (5) Evaluation of LV Systolic Function, (6) ACEI or ARB for LVSD at
Discharge, (7) Time to Fibrinolytic Therapy, (8) Time to Primary PCI, (9) Reperfusion Therapy, (10) Adult
Smoking Cessation Advice Counseling, and (11) Cardiac Rehabilitation Patient Referral From an Inpatient
Setting; and for the NSTEMI population: (1) Aspirin at Arrival, (2) Aspirin prescribed at Discharge, (3)
Beta-Blocker Prescribed at Discharge, (4) Statin Prescribed at Discharge, (5) Evaluation of LV Systolic
Function, (6) ACEI or ARB for LVSD at Discharge, (7) Adult Smoking Cessation Advice Counseling, and (8)
Cardiac Rehabilitation Patient Referral From an Inpatient Setting. A list of the aforementioned
performance indicators and their definitions is presented in Table 3 of the Appendix. The defect-free
care measure was achieved if the patient received all interventions in which they were eligible.

8

Running head: HOSPITAL VARIATION IN DEFECT FREE CARE
Statistical Analysis
The association between defect-free care and the hospital characteristics of interest: census region
of the United States, neighborhood classification, and teaching status was determined by logistic
regression. The census region variable was characterized as either Northeast, Midwest, South or West,
according to the US Census Bureau definition (Northeast included Connecticut, Maine, Massachusetts,
New Hampshire, Rhode Island, Vermont, New Jersey, New York and Pennsylvania; Midwest included
Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota
and South Dakota; South included Delaware, District of Colombia, Florida, Georgia, Maryland, North
Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas,
Oklahoma and Texas; West included Arizona, Colorado, Idaho, New Mexico, Montana, Utah, Nevada,
Wyoming, Alaska, California, Hawaii, Oregon and Washington). Neighborhood classification was
determined by location of the hospital and defined as being in either a rural, urban or suburban
community. Teaching status was determined by the hospital’s academic status.
An unadjusted, bivariate model was run for each characteristic independently. A multivariate logistic
regression was then performed. This model included all aforementioned characteristics along with
additional patient and hospital characteristics that were identified as significant through prior literature
review. The patient-level covariates included in each model were age, sex, race, cocaine use, presenting
heart rate, initial ECG findings, troponin ratio and creatinine clearance upon presentation, smoking
status, previous diagnosis of lung disease, diabetes, coronary artery disease, heart failure and atrial
fibrillation, as well as prior percutaneous coronary intervention or coronary artery bypass grafting. Age
was divided into 4 categories: age < 55, 55-64, 65-74, >= 75; race was defined as white, black, Hispanic
or other, and initial ECG findings were either ST elevation, left bundle branch block (LBBB), or isolated
posterior MI. Troponin ration was calculated as the initial troponin value (upon presentation) over the
initial troponin URL, while creatinine clearance was calculated using the following formula: (140age)*weight*(0.85 for female or 1 for male)/(72*(initial Creatinine Value)). Coronary artery disease was
defined as prior incidence of MI, PCI, or CABG.
Additional hospital characteristics of interest include bed size, hospital type (government,
community, or university), annual number of cardiac catheterizations, annual number of percutaneous
coronary interventions, public/private classification, and percentage of the hospital’s patient volume
covered by Medicare. Bed size, annual number of cardiac caths, annual number of PCIs, and percentage
of Medicare patients were divided into quartiles. The quartile divisions are as follows: bed size:
9
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Q1=0-258, Q2=259-389, Q3=390-572, Q4=573-2,000; annual number of cardiac caths: Q1=0-850,
Q2=851-1,499; Q3=1,500-2,562; Q4=2,563-13,500; annual number of PCIs: Q1=0-357, Q2=358-675,
Q3=676-1,129, Q4=1,130-4,722; and finally percentage of Medicare patients: Q1=0-42%, Q2=43-52%,
Q3=53-60%, Q4=61-100%. Descriptive statistics for variables in the multivariate model can be found in
Tables 4 and 5 in the appendix. All p-values were compared to a two-sided alpha level of 0.05.
The analyses for Tables 1 consisted of calculating frequencies for categorical variables and the
median and interquartile range for continuous variables, stratified by hospital characteristic. The
analysis for Table 2 consisted of calculating the median and interquartile range for the defect-free care
variable, stratified by year.
Data was analyzed using SAS version 9.3.

RESULTS
A total of 791,354 patients were admitted to 1,332 hospitals during the study period. After
excluding cases that did not meet the quality check (n=136,811 patients; 494 hospitals), non-adults
(n=144 patients; 5 hospitals), cases outside the study period (n=134,279 patients; 80 hospitals),
hospitals with less than 50 cases per year throughout study period (n=157,295 patients, 458 hospitals)
and patients not eligible for defect-free care (n=41,996 patients, 25 hospitals) the final cohort contained
320,829 individuals and 270 hospitals. Key characteristics and patient demographics within each hospital
category are presented in Table 1.
Number of individuals varied by region of the US, with the highest representation from the South
with 191,271 individuals, followed by 105,724 individuals from the Midwest, 44,787 individuals from the
West and 25,672 individuals from the South. The median age between the regions are similar (63-65
years); however, the regions vary by sex and race. The Northeast had the highest representation of
females (36.95%), followed by the Midwest (34.79%) and the South (34.41%), and finally the West
(32.27%). The West had the highest percentage of Hispanics (9.55%), followed by the South (4.64%),
then the Northeast (3.81%) and the Midwest (2.84). Distribution of whites also varied by US region. The
population from Northeast was composed of 90.32% white individuals, followed by the Midwest and the
West with 89.57% and 89.31% white individuals, respectively, and lastly the South with 80.38% white
individuals. The highest percent of black individuals was found in the South (16.94 %), followed by the
Midwest (8.24%), the Northeast (6.85), and the West (3.66), while 5.29% of the West, 2.26% of the
Northeast, 2.11% of the South and 1.86% of the Midwest are composed of individuals of other
10
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ethnicities. Among the study cohort 39.72% of individuals from the West presented with STEMI,
followed by 39.40% in the South, 37.86% in the Northeast and 36.52% in the Midwest. The South had
the highest rates of smokers (36.77%) followed by the Midwest (35.94%), the Northeast (30.25%) and
the West (29.73%).
Number of patients again varied by community location; 212,246 individuals were from an urban
hospital, 51,292 were from a rural hospital, and 103,916 were from a suburban hospital. Median age
was similar between community locations (63-64 years) as was percent female (approx. 34%). However,
like region of the US, race varied across types of communities. Urban hospitals had the highest
percentage of Hispanic individuals (5.02%), followed by suburban hospitals (4.98%), then rural hospitals
(2.51%). The highest percentage of whites was found at rural hospitals (89.55%), followed by suburban
hospitals (85.02%), then urban hospitals (83.56%). Urban hospitals were composed of 13.61% blacks,
while the suburban and rural hospitals were composed of 10.84% and 8.51%, respectively. Other
ethnicities had the highest representation in suburban hospitals (3.41%), followed by urban hospitals
(2.13%), and finally rural hospitals (1.73%). Smoking status varied slightly between community locations.
Rural hospitals were composed of 37.75% smokers, followed by 36.64% in urban hospitals, and 31.06%
in suburban hospitals.
Among patients in the cohort, 176,945 were treated at a teaching hospital and 190,479 were
treated at a non-teaching hospital. Proportion of females was similar between hospital types
(approximately 34%); median age was also similar (63-64 years). Race varied with non-teaching hospitals
having 87.14% whites as opposed to 82.64% in teaching hospitals. Teaching hospitals had a higher
percentage of blacks (14.42%) but a lower percentage of Hispanics (3.97%) as compared to non-teaching
hospitals (9.63% and 5.41%, respectively). Percentage of other ethnicity was similar (approximately 2%).
Clinical presentation and risk factors were similar within all characteristics. Heart rate ranged from
80-82 bpm and BMI ranged from 28.4 to 29. Hypertension was present in approximately 70-75% of
individuals; diabetes was present in approximately 30-34% of individuals. Approximately 32-38% had a
history of coronary artery disease, 21-25% had a history of MI, 10-12% had a history of cerebrovascular
disease, 10-12% had a history of heart failure and 6-8% had a history of stroke. Approximately 21-25%
had undergone a previous PCI and 11-14% had undergone a previous CABG.
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Table 1: Selected Patient Characteristics by Hospital Characteristic
Region of the US
Description

Midwest

West

Northeast

Community Location
South

Total Patients:
105724
44787
25672
191271
Demographics
Age (y):
64.00 (55.00, 75.00) 65.00 (56.00, 75.00) 65.00 (55.00, 77.00) 63.00 (54.00, 73.00)
Female
34.79
32.27
36.95
34.41
Race
Hispanic
2.84
9.55
3.81
4.64
White non-hispanic
89.57
89.31
90.32
80.38
Black non-Hispanic
8.24
3.66
6.85
16.94
Other
1.86
5.29
2.26
2.11
Clinical features on presentation
Heart Rate (beat/min)
82.00 (69.00, 97.00) 80.00 (68.00, 95.00) 82.00 (70.00, 97.00) 82.00 (69.00, 97.00)
STEMI
36.52
39.72
37.86
39.4
History and Risk Factors
BMI
29.00 (25.50, 33.40) 28.10 (24.80, 32.20) 28.40 (25.10, 36.20) 28.50 (25.10, 32.80)
Current/Recent Smoker (w/in 1 year)
35.94
29.73
30.25
36.77
Hypertension
73.35
70.27
72.87
75.41
Diabetes Mellitus
32.32
30.58
30.88
34.44
Prior CAD
36.14
32.48
32.46
37.86
Prior MI
24.18
22.59
21.49
25.81
Prior PCI
25.04
21.69
20.92
25.53
Prior CABG
13.63
10.93
12.59
14.06
Prior Heart Failure
11.84
9.99
9.88
12.27
Cerebrovascular Disease
12.25
10.94
10.43
12.27
Prior Stroke
7.46
6.83
6.41
8.16
*Categorical variables are presented as percentages
**Continuous variables are presentes as Median (Q1, Q3)

Teaching Status

Urban

Rural

Suburban

Teaching

Non-Teaching

212246

51292

103916

176975

190479

63.00 (54.00, 74.00) 64.00 (54.00, 74.00) 64.00 (55.00, 75.00)
34.12
34.51
34.91
5.02
83.56
13.61
2.13

2.51
89.55
8.51
1.73

4.98
85.02
10.84
3.41

64.00 (55.00, 74.00) 63.00 (54.00, 74.00)
34.32
34.48
3.97
82.64
14.42
2.27

5.41
87.14
9.63
2.62

81.00 (69.00, 96.00) 82.00 (69.00, 97.00) 82.00 (69.00, 97.00)
39.91
35.86
36.94

82.00 (69.00, 97.00) 82.00 (69.00, 96.00)
38.17
38.86

28.70 (25.10, 33.00) 28.70 (25.20, 33.00) 28.40 (25.10, 32.70)
36.64
37.75
31.06
73.94
74.93
73.72
33.37
33.72
32.28
36.18
38.42
35.62
24.95
25.83
23.45
24.59
25.83
24
12.99
15.29
13.47
11.55
12.66
11.53
12.09
12.36
11.54
7.68
7.97
7.52

28.50 (25.10, 32.90) 28.7 (25.10, 32.90)
35.98
34.40
74.83
73.14
33.4
32.80
36.77
35.86
25.55
23.68
24.66
24.54
13.6
13.29
12.38
10.97
12.43
11.48
7.88
7.46
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Table 2 presents use of the defect-free care measure among hospital groups, stratified by year.
Hospitals in the Northeast had higher rates of compliance than its counterparts; however, hospitals
within each region demonstrated increasing use of defect-free measure indicating increasing
compliance. Teaching hospitals started at a higher rate of use of defect-free care, however this gap
closed as compliance increased in both groups throughout the study period. Urban and suburban
hospitals demonstrated similar rates of defect-free care throughout the study period, starting at higher
levels of compliance when compared to rural hospitals. While there were positive trends among all
hospitals in this category, gaps between urban/suburban and rural hospitals persist.
Table 2: Use of The Defect-Free Care Measure Among Hospital Groups
Description
Total
Region
Northeast
Midwest
South
West
Teaching status
No
Yes
Community
Urban
Rural
Suburban

N

2010

2011

Median (Q1, Q3)
2012

2013

2014

270

67.0 (47.1, 80.6)

74.2 (56.9, 83.7)

75.8 (62.6, 85.7)

78.1 (68.0, 86.1)

79.7 (67.8, 86.6)

16
83
133
38

75.4 (62.4, 84.4)
56.7 (45.8, 79.6)
62.0 (40.0, 75.9)
62.2 (38.9, 80.7)

78.8 (70.0, 87.8)
67.9 (46.8, 81.7)
68.8 (50.0, 82.3)
70.7 (50.0, 82.7)

81.6 (72.7, 89.2)
73.0 (62.2, 81.1)
74.1 (58.0, 82.6)
73.3 (45.5, 81.9)

81.2 (73.5, 88.3)
77.4 (70.4, 86.4)
76.9 (65.4, 85.1)
74.1 (54.3, 83.7)

81.3 (72.2, 88.6)
82.3 (71.0, 86.3)
78.4 (66.7, 85.6)
77.7 (62.1, 85.7)

154
116

66.3 (44.6, 80.1)
68.0 (50.3, 81.0)

75.1 (56.0, 83.9)
70.9 (57.4, 83.2)

75.8 (59.4, 85.7)
75.9 (67.6, 85.7)

79.1 (68.0, 85.6)
77.2 (68.2, 86.5)

80.0 (67.9, 86.6)
79.3 (67.4, 86.3)

147
43
80

67.9 (45.9, 81.0)
62.9 (51.5, 75.4)
67.1 (41.3, 81.6)

74.2 (57.9, 84.6)
70.5 (56.0, 83.9)
75.6 (55.7, 83.5)

75.6 (62.6, 84.9)
73.5 (58.3, 84.3)
77.3 (65.4, 86.9)

77.6 (67.4, 85.8)
77.5 (63.9, 84.4)
80.3 (68.5, 87.3)

80.0 (67.5, 85.7)
75.2 (63.3, 89.6)
79.5 (68.9, 87.2)

The results of the logistic regression analyses are found in Table 3. In the adjusted analyses,
hospitals located in the Midwest and Northeast regions of the US were more likely to provide defectfree care (OR [95% CI]: 1.79 [1.73, 1.86] and 1.13 [1.07, 1.20], respectively) than hospitals in the South;
while hospitals located in rural or suburban areas were less likely (OR [95% CI]: 0.83 [0.80, 0.87] and
0.95 [0.92, 0.98]) to provide defect-free care than hospitals in urban areas. . In addition, teaching
hospitals are less likely to provide defect-free care (OR [95% CI]: 0.96 [0.93, 0.99]) than hospitals that are
non-teaching.
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Table 3: Unajusted and Adjusted associations between defect-free care and hospital characteristics.
UNADJUSTED LOGISTIC REGRESSIONa
DEFECT-FREE CARE USE
Characteristic
Region of US:

Midwest
Northeast
West
South
Hospital Location:
Rural
Suburban
Urban

Median (Q1, Q3)

ESTIMATE ± SE ODDS RATIO

65.7 (63.5, 77.4)
78.3 (71.8, 86.4)
72.3 (52.5, 81.4)
72.3 (56.7, 80.4)

0.44 ± 0.01
0.10 ± 0.02
-0.13 ± 0.01
REFERENCE

1.55
1.11
0.88
--

72.8 (56.8, 80.2)
75.0 (61.2, 84.2)
75.1 (59.6, 82.2)

-0.06 ± 0.00
-0.07 ± 0.01
REFERENCE

Teaching

74.4 (61.2, 81.8)

Non-Teaching

75.3 (57.9, 82.4)

0.87 ± 0.01
REFERENCE

95% CI

1.53
1.07
0.86

1.58
1.14
0.90

P VALUE

ADJUSTED LOGISTIC REGRESSION
ESTIMATE ± SE ODDS RATIO

--

<.0001
<.0001
<.0001
--

0.58 ± 0.02
0.12 ± 0.03
-0.05 ± 0.02
REFERENCE

1.79
1.13
0.95
--

0.94
0.94
--

0.92 0.96
0.92 0.95
--

<.0001
<.0001
--

-0.18 ± 0.02
-0.05 ± 0.02
REFERENCE

1.19
--

1.17 1.21

<.0001
--

-0.04 ± 0.02
REFERENCE

95% CI

1.73
1.07
0.91

P VALUEa

1.86
1.20
0.99

<.0001
<.0001
0.026
--

0.83
0.95
--

0.80 0.87
0.92 0.98
--

<.0001
0.001
--

0.96
--

0.93

--

Teaching Status:

a

--

0.99

0.010
--

--

All p values are compared to a two-sided 0.05 significance level (p<0.05). All significant p values are bolded.

DISCUSSION
Previous work utilizing data from the National Cardiovascular Data Registry (NCDR) – Acute
Coronary Treatment and Intervention Outcomes Network (ACTION) – Get With the Guidelines (AR-G)
program shows improving quality of AMI care over time [14-15]. In order to focus on overall quality of
care and to examine improvement in situations of already high compliance, a defect free “all-or-none”
composite measure is utilized. The findings of this study suggest that each of the characteristics of
interest: census region of the US, and neighborhood classification, and teaching status, are significantly
associated with providing defect-free care.
These significant findings imply that while quality of care has improved since the inception of
national quality improvement programs, significant variations in performance and gaps in care remain.
Additionally, the use of the defect-free composite measure highlights the opportunity for improvement
in both quality of care and patient outcomes, as studies have shown an inverse relationship between
composite adherence and in-hospital mortality [3,7].
Results from previous studies examining the association between regional variation and quality of
care are conflicting. While some have found significant regional variation [10-11], a study by Laskey and
colleagues utilizing GWTG-CAD data from 2000-2008 found no significant difference in use of defect-free
care by region [20]. However, since this study, the guidelines have been expanded from 6 measures to
the current 11 for STEMI or 9 for NSTEMI. This suggests the possibility of undetected variation by one of
the newer measures.

14

Running head: HOSPITAL VARIATION IN DEFECT FREE CARE
Studies examining urban/rural status and quality of care have also presented conflicting results. A
study performed by Ambardekar and colleagues examining individuals in the GWTG-CAD program from
2000-2008 found no independent association between rural status and lower compliance to
performance measures [21]. However, a study done by Baldwin and colleagues examining Medicare
beneficiaries from 2000-2001 found that patients admitted to small, rural hospitals were significantly
less likely to receive guideline-recommended treatment. Additionally, the study found no difference in
quality of care between large rural hospitals and urban hospitals [13]. The findings of this study differ
from this previous research, as it was determined that hospitals located in a rural setting are
significantly less likely to provide defect-free care. In the study performed by Ambardekar et al.,
association was determined with each performance measure independently, and high rates of
compliance were observed [21]. Thus, a potential explanation for the difference in findings is the
presence of a “ceiling effect.” By choosing the defect-free composite as the outcome of interest, this
study was able to gain an understanding of the overall quality of care and was more sensitive to
difference in adherence to guidelines that may have not been evident because of high compliance to
individual measures.
The study’s findings on the association between teaching hospitals and lower quality care differ
from previous studies that have found an association between teaching hospitals and higher quality of
care [8,12]. While the difference in findings could be a result of random variation, another explanation
could be the nature of the composite outcome. It is possible that teaching hospitals perform well when
considering the guidelines independently, but have lower rates of achieving the composite outcome
because of its “all-or-none” nature. For example, a teaching hospital may comply with the first 10 of the
composite measure components 99% of the time, but only give cardiac rehabilitation referrals 75% of
the time. When measuring compliance by individual components this hospital would be considered to
have a high level of compliance. However, when measuring compliance with the defect-free composite,
this hospital’s compliance is dependent upon providing cardiac rehabilitation referrals. Additionally, a
study performed by Patel et al. that examined compliance using a composite outcome found high rates
of variation among individual centers in these categories, with higher variation among non-teaching
hospitals. In fact, 15 of the 20 highest performing sites and 19 of the 20 lowest performing sites were
non-teaching hospitals [9].
The findings of the present study add to the evidence that variations exist by hospital
characteristics. Previous studies proved that variations in care are present when considering
15
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characteristics of the patient such as race or sex [22]. As a result, quality improvement efforts began
emphasizing and targeting these gaps. Like the earlier studies, the findings of this study highlight gaps at
the hospital level and indicate that these should qualities be taken into account when pursuing quality
improvement. Continued variation in care by hospital characteristics suggests that the institutions
within each category face unique challenges. For example, the expanded chain of command in teaching
hospitals may hinder timely administration of medications. In order to take the next step and move from
already high rates of compliance to full compliance, it must be recognized that hospital level variations
in care still exist. Further research examining the reasons behind variations in care would be useful in
determining where to focus further improvement efforts. Studies are needed to examine potential
challenges in individual hospital protocols and their association with higher or lower compliance on
individual performance measures. Once challenges are identified, solutions such as potential penalties,
incentives, process changes, and education programs, can be proposed.
This study has several limitations. First, the ACTION Registry-GWTG registry is voluntary, and thus,
participating hospitals tend to be larger, tertiary centers that may have better baseline performance.
Therefore, the extent of the variation in care based upon these characteristics may be attenuated. Next,
the study period for this analysis was limited to 2010-2015. Research has shown that duration of time in
quality improvement programs is associated with higher rates of compliance and higher quality care
[23]. Because the program began before 2010, it is possible that time in the program differed by hospital
as some may have joined before the start of our study period. This also may have influenced the effects
seen in the analysis. Additionally, there is a possibility that contraindications to specific elements are
not captured in the medical record.

CONCLUSIONS
This study evaluated the degree to which hospital performance varied on the “all-or-none”
defect-free composite measure in order to identify hospital characteristics that were predictive of
higher rates of defect-free care and provide insight into successful processes of care. Overall, the
analyses determined that use of defect-free care was significantly associated with the hospital’s region
of the US, community location (urban, rural, or suburban) and teaching status. These findings suggest
that institutions within the aforementioned categories face unique challenges. Understanding the
reasons for differences among hospitals in each category warrants further investigation.
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APPENDIX
Table 1: ACC/AHA STEMI/NSTEMI Performance Measures: Inpatient Measure Descriptions
Measure Name

Measure Description

Performance measures
1. Aspirin at arrival

AMI patients who received aspirin within 24 h before or after hospital arrival

2. Aspirin prescribed at discharge

AMI patients who are prescribed aspirin at hospital discharge

3. Beta-blocker prescribed at discharge

AMI patients who are prescribed a beta-blocker at hospital discharge

4. Statin at discharge

AMI patients who are prescribed a statin at hospital discharge

5. Evaluation of LVSF†

AMI patients with documentation in the hospital record that LVSF was evaluated during
hospitalization or is planned after discharge

6. ACEI or ARB for LVSD

AMI patients with LVSD who are prescribed an ACEI or ARB at hospital discharge (for purposes
of this measure, LVSD is defined as chart documentation of an LVEF less than 40% or a
narrative description of LVSF consistent with moderate or severe systolic dysfunction)

Median time from hospital arrival to administration of fibrinolytic therapy in AMI patients
with ST-segment elevation or LBBB on the ECG performed closest to hospital arrival time; AMI
7. Time to fibrinolytic therapy
patients with ST-segment elevation or LBBB on the ECG closest to hospital arrival time
receiving fibrinolytic therapy during the hospital stay with a time from hospital arrival to
fibrinolysis of 30 min or less
Median time from hospital arrival to primary PCI in AMI patients with ST-segment elevation
or LBBB on the ECG performed closest to arrival time; AMI patients with ST-segment
8. Time to PCI
elevation or LBBB on the ECG closest to hospital arrival time receiving primary PCI during the
hospital stay with a time from hospital arrival to PCI of 90 min or less
AMI patients with ST-segment elevation or LBBB on the ECG performed closest to arrival
9. Reperfusion therapy
receiving either fibrinolysis or primary PCI or who are transferred to another facility for
primary PCI
10. Time from ED arrival at STEMI referral facility to ED
Median time from ED arrival at STEMI referral facility to ED discharge from STEMI referral
discharge from STEMI referral facility in patients transferred for facility for AMI patients with ST-segment elevation or LBBB on the ECG performed closest to
primary PCI†
hospital arrival time who are transferred to a STEMI receiving facility for primary PCI
Median time from patient arrival at a STEMI referral facility's ED to time of primary PCI at a
11. Time from ED arrival at STEMI referral facility to primary PCI STEMI receiving facility for AMI patients presenting with ST-segment elevation or LBBB on the
at STEMI receiving facility among transferred patients †
ECG performed closest to first hospital arrival time who are transferred to a STEMI receiving
facility for primary PCI
AMI patients with a history of smoking cigarettes who are given smoking cessation advice or
12. Adult smoking cessation advice/counseling
counseling during hospital stay
13. Cardiac rehabilitation patient referral from an inpatient
All patients hospitalized with a primary diagnosis of AMI referred to an early outpatient CR
setting†(6)
program
Test measures
T-1. LDL cholesterol assessment

AMI patients with documentation of LDL cholesterol level in the hospital record or
documentation that LDL cholesterol testing was done during the hospital stay or is planned
after discharge

T-2. Excessive initial heparin dose†

AMI patients who receive excess dosing of UFH initially

T-3. Excessive initial enoxaparin dose†

AMI patients who receive excess dosing of subcutaneous enoxaparin initially

T-4. Excessive initial abciximab dose†

AMI patients who receive excess dosing of abciximab initially

T-5. Excessive initial eptifibatide dose†

AMI patients who receive excess dosing of eptifibatide initially

T-6. Excessive initial tirofiban dose†

AMI patients who receive excess dosing of tirofiban initially

T-7. Anticoagulant dosing protocol†

T-8. Anticoagulant error tracking system†
T-9. Clopidogrel prescribed at discharge for medically treated
AMI patients†

Presence of a protocol or other clinical aid (eg, nomogram, electronic order entry) in the
hospital record of AMI patients that addresses dosing of anticoagulant therapy and
parenteral antiplatelet therapy (ie, UFH, low-molecular-weight heparin, and glycoprotein
IIb/IIIa inhibitors)
Evidence of a tracking system for identifying dosing errors in anticoagulation therapy in the
hospital record of AMI patients.
Medically treated AMI patients who are prescribed clopidogrel or ticlopidine at hospital
discharge

Test measures have been designated for use in internal quality improvement programs only and are not appropriate for any other use, eg, pay for
performance, physician ranking, or public reporting programs.
†New measures.
LVEF indicates left ventricular ejection fraction; LBBB, left bundle-branch block; ECG, electrocardiographic; ED, emergency department; CR, cardiac
rehabilitation/secondary prevention; and UFH, unfractionated heparin.
Krumholz, H. M., Anderson, J. L., Bachelder, B. L., Fesmire, F. M., Fihn, S. D., Foody, J. M., ... & Nallamothu, B. K. (2008). ACC/AHA 2008 performance measures
for adults with ST-elevation and non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task
Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non–ST-Elevation Myocardial Infarction)
developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American
Association of Cardiovascular and .... Journal of the American College of Cardiology , 52 (24), 2046-2099.
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Table 2: ACTION-GWTG Data Elements
Category

Example Elements

Patient demographics

Age, s ex, ra ce, i ns ura nce s ta tus

Medi ca l hi s tory a nd
ri s k fa ctors

Hei ght, wei ght, hypertens i on, di a betes
mel l i tus , dys l i pi demi a , peri phera l
a rteri a l di s ea s e, current s moker, pri or
ca rdi a c hi s tory, pri or reva s cul a ri za tion

Hospital presentation

Ini tia l ca rdi a c s ta tus

Medications and
associated doses

Reperfus i on s tra tegy

Procedures

La b va l ues
Outcomes

Tra ns fer s ta tus , da te/time of fi rs t
medi ca l conta ct, a rri va l da te/time,
da te/time of fi rs t ECG, l oca tion of
i ni tia l eva l ua tion
ECG fi ndi ngs , hea rt ra te, s ys tol i c bl ood
pres s ure, ca rdi ogeni c s hock, hea rt
fa i l ure
Antipl a tel et a gents , wa rfa ri n,
unfra ctiona ted hepa ri n, l ow mol ecul a r
wei ght hepa ri n, bi va l i rudi n,
fonda pa ri nux, GP IIb-IIIa i nhi bi tors , βbl ockers , ACE i nhi bi tors , a ngi otens i n
receptor bl ockers , a l dos terone bl ocki ng
a gents , l i pi d-l oweri ng a gents
Thrombol ytic da te/time, pri ma ry PCI
da te/time, res cue PCI da te/time,
nons ys tems rea s on for del a y i n
reperfus i on
LVEF a s s es s ment, di a gnos tic
ca theteri za tion, PCI (other tha n
pri ma ry), CABG
Ca rdi a c ma rkers , l i pi d pa nel ,
crea tini ne, hemogl obi n, hemogl obi n
A1C, INR, BNP
Dea th, re-MI, bl eedi ng, tra ns fus i on,
hea rt fa i l ure ca rdi ogeni c s hock, s troke

GP indicates glycoprotein; ACE, angiotensin-converting enzyme; PCI,
percutaneous coronary intervention; LVEF, left ventricular ejection
fraction; CAGB, coronary artery bypass graft; INR, international normalized
ratio; and BNP, b-type natriuretic peptide.
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Table 3: NCDR AR-G "All-or-None" Defect-Free Composite Measure Components
Performance Indicator

Definition

(1) Aspirin at Arrival

AMI pa ti ents who recei ved a s pi ri n wi thi n 24 h before or a fter
hos pi tal a rri va l

(2) As pi ri n pres cri bed a t Di s cha rge

AMI pa ti ents who a re pres cri bed a s pi ri n a t hos pi tal di s cha rge

(3) Beta-Bl ocker Pres cri bed a t Di s cha rge

AMI pa ti ents who a re pres cri bed a beta-bl ocker a t hos pi tal
di s cha rge

(4) Stati n Pres cri bed a t Di s cha rge

AMI pa ti ents who a re pres cri bed a s tati n a t hos pi tal di s cha rge

(5) Eva l ua ti on of LV Sys tol i c Functi on

AMI pa ti ents wi th documentati on i n the hos pi tal record tha t LVSF
wa s eva l ua ted duri ng hos pi tal i za ti on or i s pl a nned a fter di s cha rge

(6) ACEI or ARB for LVSD a t Di s cha rge

AMI pa ti ents wi th LVSD who a re pres cri bed a n ACEI or ARB a t
hos pi tal di s cha rge (for purpos es of thi s mea s ure, LVSD i s defi ned
a s cha rt documentati on of a n LVEF l es s tha n 40% or a na rra ti ve
des cri pti on of LVSF cons i s tent wi th modera te or s evere s ys tol i c
dys functi on)

(7) Ti me to Fi bri nol yti c Thera py

Medi a n ti me from hos pi tal a rri va l to a dmi ni s tra ti on of fi bri nol yti c
thera py i n AMI pa ti ents wi th ST-s egment el eva ti on or LBBB on the
ECG performed cl os es t to hos pi tal a rri va l ti me; AMI pa ti ents wi th STs egment el eva ti on or LBBB on the ECG cl os es t to hos pi tal a rri va l
ti me recei vi ng fi bri nol yti c thera py duri ng the hos pi tal s tay wi th a
ti me from hos pi tal a rri va l to fi bri nol ys i s of 30 mi n or l es s

(8) Ti me to Pri ma ry PCI

Medi a n ti me from hos pi tal a rri va l to pri ma ry PCI i n AMI pa ti ents
wi th ST-s egment el eva ti on or LBBB on the ECG performed cl os es t to
a rri va l ti me; AMI pa ti ents wi th ST-s egment el eva ti on or LBBB on the
ECG cl os es t to hos pi tal a rri va l ti me recei vi ng pri ma ry PCI duri ng the
hos pi tal s tay wi th a ti me from hos pi tal a rri va l to PCI of 90 mi n or
l es s

(9) Reperfus i on Thera py

AMI pa ti ents wi th ST-s egment el eva ti on or LBBB on the ECG
performed cl os es t to a rri va l recei vi ng ei ther fi bri nol ys i s or pri ma ry
PCI or who a re tra ns ferred to a nother fa ci l i ty for pri ma ry PCI

(10) Adul t Smoki ng Ces s a ti on Advi ce Couns el i ng
(11) Ca rdi a c Reha bi l i tati on Pa ti ent Referra l From a n Inpa ti ent Setti ng

AMI pa ti ents wi th a hi s tory of s moki ng ci ga rettes who a re gi ven
s moki ng ces s a ti on a dvi ce or couns el i ng duri ng hos pi tal s tay
Al l pa ti ents hos pi tal i zed wi th a pri ma ry di a gnos i s of AMI referred
to a n ea rl y outpa ti ent CR progra m
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Table 4: Selected Patient Characteristics by Hospital Characteristic
Region of the US
Description

Midwest

West

Northeast

South

N
105724
44787
25672
191271
Demographics
Age (y):
64.00 (55.00, 75.00)
65.00 (56.00, 75.00)
65.00 (55.00, 77.00)
63.00 (54.00, 73.00)
Age Groups
Age<55
24.92
22.16
23.17
26.74
Age 55 to <64
26.57
27.47
25.44
27.42
Age 65 to <74
22.63
24.15
22.04
23.62
Age>=75
25.88
26.21
29.35
22.21
Female
34.79
32.27
36.95
34.41
Race
Hispanic
2.84
9.55
3.81
4.64
White non-hispanic
89.57
89.31
90.32
80.38
Black non-Hispanic
8.24
3.66
6.85
16.94
Other
1.86
5.29
2.26
2.11
Insurance
Medicare
49.47
48.12
50.76
49.94
Medicaid or not private
14.27
19.04
10.97
14.61
Private
62.57
57.19
72.26
53.33
None
10.47
9.84
4.89
13.78
Clinical features on presentation
Heart Rate (beat/min)
82.00 (69.00, 97.00)
80.00 (68.00, 95.00)
82.00 (70.00, 97.00)
82.00 (69.00, 97.00)
Systolic Blood Pressure (mm Hg)
147.00 (126.00, 168.00) 144.00 (124.00, 165.00) 145.00 (125.00, 166.00) 146.00 (126.00, 168.00)
STEMI
36.52
39.72
37.86
39.4
Cardiogenic Shock
3.36
4.32
2.91
3.51
History and Risk Factors
BMI
29.00 (25.50, 33.40)
28.10 (24.80, 32.20)
28.40 (25.10, 36.20)
28.50 (25.10, 32.80)
Current/Recent Smoker (w/in 1 year)
35.94
29.73
30.25
36.77
Hypertension
73.35
70.27
72.87
75.41
Dyslipidemia
60.66
57.88
60.72
60.06
Currently on Dialysis
2.36
2.27
1.97
2.55
Chronic Lung Disease
15.03
11.96
11.22
13.89
Diabetes Mellitus
32.32
30.58
30.88
34.44
Prior CAD
36.14
32.48
32.46
37.86
Prior MI
24.18
22.59
21.49
25.81
Prior PCI
25.04
21.69
20.92
25.53
Prior CABG
13.63
10.93
12.59
14.06
Prior Heart Failure
11.84
9.99
9.88
12.27
Atrial Fibrillation or Flutter Past 2 Weeks
6.77
6.91
7.48
6.65
Cerebrovascular Disease
12.25
10.94
10.43
12.27
Prior Stroke
7.46
6.83
6.41
8.16
Peripheral Arterial Disease
10.34
8.18
8.13
9.65
Lab values on presentation
Troponin Ratio
2.00 (0.43, 12.38)
2.33 (0.47, 14.25)
3.27 (0.67, 20.00)
2.00 (0.500, 13.14)
CKMB Ratio
1.05 (0.45, 3.675
1.21 (0.49, 4.84)
1.32 (0.55, 4.86)
1.16 (0.48, 4.24)
Creatinine (mg/dL)
1.00 (0.90, 1.30)
1.00 (0.90, 1.30)
1.00 (0.80, 1.30)
1.00 (0.90, 1.30)
Creatinine Clearance
81.20 (54.22, 111.65)
79.42 (53.91, 107.78)
80.95 (52.76, 112.38)
81.92 (55.39, 111.61)
Hemoglobin (g/dL)
14.1 (12.6, 15.3)
14.30 (12.90, 15.60)
13.90 (12.50, 15.20)
14.00 (12.50, 15.20)
Hemoglobin A1c
6.20 (5.70, 7.50)
6.10 (5.60, 7.40)
6.00 (5.60, 7.10)
6.10 (5.60, 7.50)
INR
1.00 (1.00, 1.10)
1.00 (1.00, 1.10)
1.00 (1.00, 1.10)
1.00 (1.00, 1.10)
Total Cholesterol (mg/dL)
164.00 (135.00, 195.00) 162.00 (134.00, 195.00) 164.00 (136.00, 196.00) 165.00 (136.00, 197.00)
HDL Cholesterol (mg/dL)
38.00 (31.00, 46.00)
38.00 (31.00, 46.00)
40.00 (33.00, 49.00)
37.00 (30.00, 46.00)
LDL Cholesterol (mg/dL)
95.00 (70.00, 123.00)
94.00 (69.00, 122.00)
94.00 (69.00, 122.00)
97.00 (72.00, 125.00)
Triglycerides (mg/dL)
123.00 (85.00, 183.00) 122.00 (84.00, 182.00) 119.00 (83.00, 175.00) 124.00 (84.00, 186.00)
Lipid Panel Values Out of Range
6.45
4.89
4.69
7.3
BNP (pg/mL)
213.00 (60.00, 627.00) 236.00 (71.00, 622.00) 297.00 (84.00, 811.00) 203.00 (58.00, 599.00)
NT-proBNP (pg/mL)
1255.00 (253.00, 4463.00)1165.50 (220.00, 4422.00)1019.00 (214.00, 3699.00)1200.00 (247.00, 4610.00)
*Categorical variables are presented as percentages
**Continuous variables are presentes as Median (Q1, Q3)
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Table 4: Selected Patient Characteristics by Hospital Characteristic (con't)
Community Location

Teaching Status

Description

Urban

Rural

Suburban

Teaching

Non-Teaching

N
Demographics
Age (y):
Age Groups

212246

51292

103916

176975

190479

63.00 (54.00, 74.00)

64.00 (54.00, 74.00)

64.00 (55.00, 75.00)

64.00 (55.00, 74.00)

63.00 (54.00, 74.00)

26.16
27.6
23.13
23.1
34.12

25.04
26.82
24.05
24.08
34.51

24.07
26
23.23
26.69
34.91

25.98
27.51
22.93
23.57
34.32

24.80
26.53
23.67
24.99
34.48

5.02
83.56
13.61
2.13

2.51
89.55
8.51
1.73

4.98
85.02
10.84
3.41

3.97
82.64
14.42
2.27

5.41
87.14
9.63
2.62

49.25
16.51
55.76
12.00

52.67
17.14
54.47
12.36

48.18
10.19
64.03
10.86

49.64
16.03
57.59
11.78

49.64
13.48
57.98
11.67

82.00 (69.00, 97.00)
146.00 (126.00, 168.00)
35.86
3.38

82.00 (69.00, 97.00)
147.00 (126.00, 168.00)
36.94
3.33

82.00 (69.00, 97.00)
146.00 (126.00, 168.00)
38.17
3.34

82.00 (69.00, 96.00)
146.00 (125.00, 167.00)
38.86
3.72

28.70 (25.20, 33.00)
37.75
74.93
62.63
2.08
16.71
33.72
38.42
25.83
25.83
15.29
12.66
6.9
12.36
7.97
10.01

28.40 (25.10, 32.70)
31.06
73.72
61.24
2.46
12.74
32.28
35.62
23.45
24
13.47
11.53
7.43
11.54
7.52
9.45

28.50 (25.10, 32.90)
35.98
74.83
61.73
2.45
13.27
33.4
36.77
25.55
24.66
13.6
12.38
6.75
12.43
7.88
9.98

28.7 (25.10, 32.90)
34.40
73.14
58.17
2.38
14.04
32.80
35.86
23.68
24.54
13.29
10.97
6.80
11.48
7.46
9.12

2.00 (0.50, 11.20)
1.03 (0.45, 3.39)
1.00 (0.90, 1.30)
81.24 (55.03, 115.51)
14.10 (12.60, 15.30)
6.20 (5.70, 7.50)
1.00 (1.00, 1.10)
165.00 (137.00, 197.00)
37.00 (31.00, 45.00)
96.00 (71.00, 124.00)
126.00 (87.00, 190.00)
6.55
208.00 (62.00, 605.00)
1243.00 (266.00, 4800.00)

2.07 (0.50, 13.15)
1.13 (0.47, 4.06)
1.10 (0.90, 1.30)
79.01 (52.48, 108.55)
14.00 (12.60, 15.30)
6.10 (5.60, 7.50)
1.00 (1.00, 1.10)
163.00 (135.00, 195.00)
38.00 (31.00, 47.00)
95.00 (70.00, 123.00)
121.00 (83.00, 180.00)
6.96
219.00 (60.00, 647.00)
1045.00 (211.00, 3970.00)

1.75 (0.40, 10.60)
1.12 (0.48, 3.89)
1.00 (0.90, 1.30)
80.21 (54.06, 109.86)
14.10 (12.60, 15.30)
6.20 (5.70, 7.60)
1.00 (1.00, 1.10)
164.00 (136.00, 195.00)
37.00 (31.00, 46.00)
95.00 (71.00, 123.00)
124.00 (85.00, 185.00)
7.24
216.00 (60.00, 621.00)
1086.00 (220.00, 4249.50)

2.56 (0.56, 16.56)
1.18 (0.48, 4.47)
1.00 (0.80, 1.30
82.39 (55.27, 112.45)
14.00 (12.50, 15.30)
6.10 (5.60, 7.40)
1.00 (1.00, 1.10)
165.00 (136.00, 196.00)
38.00 (31.00, 46.00)
96.00 (71.00, 124.00)
122.00 (84.00, 182.00)
5.87
214.00 (63.00, 623.00)
1316.50 (270.00, 4762.00)

Age<55
Age 55 to <64
Age 65 to <75
Age>=75

Female
Race
Hispanic
White non-hispanic
Black non-Hispanic
Other

Insurance
Medicare
Medicaid or not private
Private
None

Clinical features on presentation
Heart Rate (beat/min)
81.00 (69.00, 96.00)
Systolic Blood Pressure (mm Hg)
146.00 (125.00, 167.00)
STEMI
39.91
Cardiogenic Shock
3.65
History and Risk Factors
BMI
28.70 (25.10, 33.00)
Current/Recent Smoker (w/in 1 year)
36.64
Hypertension
73.94
Dyslipidemia
58.78
Currently on Dialysis
2.48
Chronic Lung Disease
13.61
Diabetes Mellitus
33.37
Prior CAD
36.18
Prior MI
24.95
Prior PCI
24.59
Prior CABG
12.99
Prior Heart Failure
11.55
Atrial Fibrillation or Flutter Past 2 Weeks
6.42
Cerebrovascular Disease
12.09
Prior Stroke
7.68
Peripheral Arterial Disease
9.51
Lab values on presentation
Troponin Ratio
2.20 (0.50, 14.33)
CKMB Ratio
1319 (0.50, 4.49)
Creatinine (mg/dL)
1.00 (0.90, 1.30)
Creatinine Clearance
82.56 (55.71, 112.47)
Hemoglobin (g/dL)
14.10 (12.60, 15.30)
Hemoglobin A1c
6.10 (5.60, 7.50)
INR
1.00 (1.00, 1.10)
Total Cholesterol (mg/dL)
164.00 (136.00, 196.00)
HDL Cholesterol (mg/dL)
37.00 (31.00, 46.00)
LDL Cholesterol (mg/dL)
96.00 (71.00, 124.00)
Triglycerides (mg/dL)
123.00 (85.00, 184.00)
Lipid Panel Values Out of Range
6.40
BNP (pg/mL)
215.00 (62.00, 613.00)
NT-proBNP (pg/mL)
1291.00 (258.00, 4739.00)
*Categorical variables are presented as percentages
**Continuous variables are presentes as Median (Q1, Q3)
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Table 5: Selected Hospital Characteristics
Hospital Characteristic
ALL
270
Total beds:
1200 (700, 2031)
Hospital Bed Size
0-258
83
259-389
72
390-572
64
573-2000
51
Annual Number of PCIs
0-357
90
358-675
73
676-1129
62
1130-4722
45
Annual Number of Cardiac Caths
0-850
87
851-1499
79
1500-2562
55
2563-13500
47
Percentage of Medicare Patients
0-42%
62
43-52%
73
53-60%
48
61-100%
87
Hospital Type
Government
5
Community
236
University
29
Public/Private
Public
156
Private
114
Region
Northeast
16
Midwest
83
South
133
West
38
Teaching status
Non-Teaching
154
Teaching
116
Community Location
Rural
43
Urban
147
Suburban
80
*Category sums may not equal the total hospital number due to
unknowns values
**Categorical variables are presented as percentages
***Continuous variables are presentes as Median (Q1, Q3)
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